PT Ikapharmindo Putramas Tbk (IDX:IKPM)
Indonesia · Delayed Price · Currency is IDR 193.00
-1.00 (-0.52%)
At close: May 26, 2026
IDX:IKPM Revenue
PT Ikapharmindo Putramas Tbk had revenue of 103.84B IDR in the quarter ending March 31, 2026, with 14.99% growth. This brings the company's revenue in the last twelve months to 377.10B, down -6.90% year-over-year. In the year 2025, PT Ikapharmindo Putramas Tbk had annual revenue of 363.57B, down -11.77%.
Revenue (ttm)
377.10B
Revenue Growth
-6.90%
P/S Ratio
0.86
Revenue / Employee
365.76M
Employees
1,031
Market Cap
325.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 363.57B | -48.50B | -11.77% |
| Dec 31, 2024 | 412.07B | -29.07B | -6.59% |
| Dec 31, 2023 | 441.14B | 42.40B | 10.63% |
| Dec 31, 2022 | 398.73B | 17.82B | 4.68% |
| Dec 31, 2021 | 380.92B | -334.88B | -46.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 36.21T |
| PT Siloam International Hospitals Tbk | 13.09T |
| PT Mitra Keluarga Karyasehat Tbk | 5.45T |
| PT Millennium Pharmacon International Tbk | 4.15T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.64T |
| PT Phapros Tbk | 961.30B |
| PT Royal Prima Tbk | 329.89B |
| PT Indofarma Tbk | 206.24B |